(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 86.21% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.6%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 11.01%.
Cvrx's revenue in 2023 is $18,951,000.On average, 3 Wall Street analysts forecast CVRX's revenue for 2023 to be $819,990,717, with the lowest CVRX revenue forecast at $790,226,018, and the highest CVRX revenue forecast at $872,768,511. On average, 2 Wall Street analysts forecast CVRX's revenue for 2024 to be $1,226,919,036, with the lowest CVRX revenue forecast at $1,185,441,947, and the highest CVRX revenue forecast at $1,268,396,124.
In 2025, CVRX is forecast to generate $2,052,652,734 in revenue, with the lowest revenue forecast at $2,052,652,734 and the highest revenue forecast at $2,052,652,734.